Reduced contrast CT lowers cost, risk in elderly patients
Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality.
Elderly patients can undergo CT scanning of the pancreatobiliary region with only 90% or less of the contrast dose required in other patients without compromising the exam's quality. A lower dose could also reduce costs and the risk of complications.
Dr. Shigeki Itoh, a radiologist at Nagoya University School of Health Science in Japan, and colleagues assessed 112 patients who had undergone triple-phase contrast-enhanced CT exams on a 16-slice scanner for known or suspected pancreatobiliary disease. They split the patients into three groups according to age and weight (AJR 2006 Aug;187[2]:505-510).
The investigators found that after a 12.2% reduction in the volume and rate of contrast injection, they could achieve equivalent contrast enhancement in patients older than 60 as compared with patients aged 60 or younger undergoing scanning with a standard dose.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.
